News

Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment. Scientists from the National University of Singapore (NUS) recently showed…
Read More...

Immunocore Limited announced an investment from the Bill & Melinda Gates Foundation to support the development of Immunocore's soluble TCR-based therapeutics for infectious…
Read More...

Regeneron Pharmaceuticals and Sanofi announced positive results from the Phase 3 CAFÉ study of DUPIXENT® (dupilumab) in adults with moderate-to-severe atopic dermatitis (AD) who are…
Read More...

Thrombolytic Science, LLC (TSI) announced the completion of a Phase 1 clinical trial of TS01, a new-generation clot-dissolving therapy aimed at the treatment of clot-induced diseases…
Read More...

Eurofins Scientific announces that it has signed an agreement to acquire EAG Laboratories from Odyssey Investment Partners. The transaction is expected to close in the next few months,…
Read More...

Absorption Systems announces a formal Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA). The goals are to improve the FDA's ability to predict…
Read More...

Arcus Biosciences, a US-based biotechnology company focused on the discovery and development of innovative cancer immunotherapies, announced that it has entered into an option and…
Read More...

FUJIFILM Diosynth Biotechnologies has announced its opening of the 10,000 square foot, state-of-the-art cell culture Process Development Laboratories in Wilton Centre, Teesside. These…
Read More...

Boehringer Ingelheim announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the Marketing…
Read More...

Ambry Genetics Corporation announces integration between their secure AmbryPort 2.0 (AP2) clinician ordering platform and FDNA’s Face2Gene® suite of applications. This integration is…
Read More...

Bristol-Myers Squibb Company and Halozyme Therapeutics, Inc. announced a global collaboration and license agreement to develop subcutaneously administered Bristol-Myers Squibb…
Read More...

MilliporeSigma announced that Celonic AG, a Swiss contract development and manufacturing organization (CDMO), is upgrading its manufacturing facility with five of MilliporeSigma's…
Read More...

Agilent Technologies Inc. has announced that it has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the GenetiSure Dx Postnatal Assay: its first…
Read More...

Evotec AG and MaRS Innovation announced the launch of "LAB150". This transformational Toronto-based partnership will give Canadian academic institutions and teaching hospitals access to…
Read More...

Bormioli Rocco Pharma is strengthening its services in North America for pharmaceutical glass packaging with a dedicated sales team and innovative products, particularly for high-value…
Read More...

HanAll Biopharma and Harbour BioMed announced that they have entered into a strategic collaboration and license agreement to develop, manufacture and commercialize in Greater China …
Read More...

Pascal Biosciences announced that the Company has executed an exclusive, worldwide license option agreement with STC.UNM (“STC”), the University of New Mexico’s technology-transfer and…
Read More...

AbCellera Biologics, Inc. announced that it has entered into an antibody discovery research collaboration with GSK, whereby AbCellera will apply its high-throughput single-cell antibody…
Read More...

Merck has announced that it will enter into a strategic collaboration with Project Data Sphere LLC, an independent, not-for-profit initiative of the CEO Roundtable on Cancer's Life…
Read More...

Adaptimmune Therapeutics plc announced that GlaxoSmithKline plc has exercised its option under a collaboration and license agreement signed in 2014 to exclusively license the right to…
Read More...